Your browser doesn't support javascript.
loading
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia.
Enshaei, Amir; O'Connor, David; Bartram, Jack; Hancock, Jeremy; Harrison, Christine J; Hough, Rachael; Samarasinghe, Sujith; den Boer, Monique L; Boer, Judith M; de Groot-Kruseman, Hester A; Marquart, Hanne V; Noren-Nystrom, Ulrika; Schmiegelow, Kjeld; Schwab, Claire; Horstmann, Martin A; Escherich, Gabriele; Heyman, Mats; Pieters, Rob; Vora, Ajay; Moppett, John; Moorman, Anthony V.
Affiliation
  • Enshaei A; Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • O'Connor D; Department of Haematology, Great Ormond Street Hospital, London, United Kingdom.
  • Bartram J; Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Hancock J; Department of Haematology, Great Ormond Street Hospital, London, United Kingdom.
  • Harrison CJ; Bristol Genetics Laboratory, North Bristol National Health Service Trust, Bristol, United Kingdom.
  • Hough R; Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Samarasinghe S; Department of Haematology, University College Hospital, London, United Kingdom.
  • den Boer ML; Department of Haematology, Great Ormond Street Hospital, London, United Kingdom.
  • Boer JM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • de Groot-Kruseman HA; Dutch Childhood Oncology Group, Utrecht, The Netherlands.
  • Marquart HV; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Noren-Nystrom U; Dutch Childhood Oncology Group, Utrecht, The Netherlands.
  • Schmiegelow K; Department Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Schwab C; Pediatrics Unit, Department of Clinical Sciences, Umeå University, Umeå, Sweden.
  • Horstmann MA; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Escherich G; Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Heyman M; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg, Germany.
  • Pieters R; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg, Germany.
  • Vora A; Department of Pediatric Oncology, Karolinska University Hospital-Karolinska Institutet, Stockholm, Sweden; and.
  • Moppett J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Moorman AV; Department of Haematology, Great Ormond Street Hospital, London, United Kingdom.
Blood ; 135(17): 1438-1446, 2020 04 23.
Article in En | MEDLINE | ID: mdl-32315382

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Outcome Assessment, Health Care / Patient Selection / Neoplasm, Residual / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Blood Year: 2020 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Outcome Assessment, Health Care / Patient Selection / Neoplasm, Residual / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Blood Year: 2020 Document type: Article Affiliation country: